Graphique 1 - Toubkal

52- Naber KG.- Experience with the new guidelines on evaluation of new anti-infective drugsfor the treatment of urinary tract infections.- Int J Antimicrob Agents 1999;11:(3,4)189-96, discussion 213-6.53- Rubin RH, Shapiro ED et al.- Evaluation of new anti-infective drugs for the treatment of urinary tractinfection. Infectious Diseases Society of America and the Food and DrugAdministration.- Clin Infect Dis 1992;15(Suppl.1)S216-27.54- Rubin RH, Shapiro ED et al.- Whith modifications by a European Working Party (Norrby SR), Generalguidelines for the evaluation of new anti-infective drugs for the treatmentof UTI. Taufkirchen, Germany.- clin Infect Dis, 1993 ; 294-310.55- Farrell DJ, Morrissey I, Rubeis D et al.- A UK multicentre study of the antimicrobial susceptibility of bacterialpathogens causing urinary tract infection.- J Infect 2003;46(2):94-100.56- Guneysel O, Onur O, Erdede M et al.- Trimethoprim/ sulfamethoxazol resistance in urinary tract infections.- J Emergency Medicine 2009 ;36(4) : 338-341.57- Lutter SA, Currie ML, Mitz LB et al.- Antibiotic resistance patterns in children hospitalized for urinary tractinfections.- Arch Pediatr Adolesc Med. 2005;159 (10) : 924–928.165